ROMAN MACK: Open Payments
NPI 1831178839 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $127 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $44 |
| Amgen Inc. | 3 | $43 |
| Dexcom, Inc. | 2 | $34 |
| SHIELD THERAPEUTICS INC | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Dexcom G6 Transmitter, ACCRUFER, QULIPTA, OTEZLA, ELIQUIS, UNITHROID, UBRELVY, REPATHA.
Industry payments across PA — which companies pay providers there.
